AKT1 and renal fibrosis: Recently, Yamamoto et al. (20) showed that EGFR blocking by erlotinib alone protected against RFF in 5/6-nephrectomized rats via inhibition of Akt and ERK 1/2 signaling pathways, which were closely associated with renal fibrosis.